Michael Weller

The Lancet Oncology · 2002–2020

A researcher in the Science corpus: 34 papers; trusts 0 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Whom Michael Weller trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Louis
  2. Wolfgang Wick
  3. P. Wen
  4. Stanton L. Gerson
  5. A. E. Pegg
  6. Manel Esteller
  7. Frank M. Sacks
  8. Q. Ostrom

Who trusts Michael Weller overall

  1. C. Lord
  2. Simone Fulda
  3. Alan Ashworth

Papers from Michael Weller's perspective

Ordered by how strongly the researchers Michael Weller trusts endorse each paper. Same corpus, a different order for every researcher.

  1. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. (Journal of Clinical Oncology)
  2. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. (Journal of Clinical Oncology)
  3. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. (Radiology)
  4. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (New England Journal of Medicine)
  5. MethyLight: a high-throughput assay to measure DNA methylation. (Nucleic Acids Research)
  6. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. (Neuro-Oncology)
  7. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. (Journal of Clinical Oncology)
  8. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. (DNA Repair)
  9. Analysis of the IDH1 codon 132 mutation in brain tumors (Acta Neuropathologica)
  10. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. (The Lancet)

Their papers